Subcutaneous infection chambers in rabbits were infected with a strain of Staphylococcus aureus isolated from a patient with toxic shock syndrome. Estrogens (mestranol and 17-,3-estradiol) protected male rabbits and prolonged survival. Neither androgens (testosterone and dihydrotestosterone) nor progesterone affected the susceptibility of intact or ovarihysterectomized female rabbits.
There have been several approaches to developing an animal model for the study of toxic shock syndrome (TSS (12) and chicken embryos (5) . Previous reports from this laboratory described the use of subcutaneous infection chambers in New Zealand White rabbits which permit a controlled, localized infection with S. aureus strains (3, 13) . This model has also been used by Arko et al. (1), Garbe et al. (6) , and Rasheed et al. (11) to characterize TSS strains.
We recently reported that male rabbits are more susceptible to the lethal effects of an infection with a TSS strain than are female rabbits and that castration abolished this difference (3) . Because sex steroids have been shown by others to affect a variety of infections in other experimental animals (8) (9) (10) 14) , the present study was undertaken to determine whether the mortality observed in rabbits infected with a TSS strain of S. aureus could be affected by sex steroid pretreatment and whether there was a relationship between observed mortality and the circulating levels of these sex steroids. The organism used was isolated from a 14-year-old female patient by J. Todd (Children's Hospital of Denver, Denver, Colo.). This strain, designated 555, was found in earlier studies to be virulent for male rabbits (3, 13) .
New Zealand White rabbits of two ages were used. The younger rabbits were purchased at 15 weeks of age and infected when 6 months old. Older rabbits were purchased at 6 months of age and infected when 9 months old. All the rabbits were anesthetized with intramuscular ketamine (75 mg/kg [body weight]) and xylazine (7.5 mg/kg) before the surgical implantation of a sterile polyethylene chamber (Sportsotron, Inc., Bohemia, N.Y.) through a midline dorsal incision in the flank region. For studies with neutered animals, the testes or both ovaries and the uterus were removed under ketamine-xylazine anesthesia 10 to 14 days before infection. Rabbits which were to receive hormone implants (see below) were neutered 4 weeks before infection.
Sex steroids were given in the form of continuous-release pellets (Innovative Research of America, Rockville, Md.). The pellets contained either 25 or 100 mg of steroid with a carrier-binder composed of cholesterol-methyl cellulose-alactose; they provide 3 weeks of controlled hormone release after subcutaneous implantation.
Testosterone and progesterone (P4) were assayed in blood samples obtained from the median ear artery just before infection. The steroid was extracted from serum by a diethyl ether, dry ice-methanol procedure with tracer quantities of labeled steroid included to determine recovery. The radioimmunoassay performed was described previously (7) . The sensitivity of the radioimmunoassay for testosterone was 10 pg, the linear range was 10 to 150 pg, and the inter-and intraassay coefficients of variation were 7.5 and 5.1%, respectively. For P4 the sensitivity was 18.8 pg with a linear range of 18.8 to 300 pg on the standard curve. The inter-and intraassay coefficients of variation were 9.9 and 3.4%, respectively.
To determine whether estrogen protected male rabbits, subcutaneous hormone pellets were implanted 10 days before the rabbits were infected with 109 CFU of S. aureus 555.
Estrogens protected male rabbits in three separate experiments (Table 1) . In experiments 1 and 2, the synthetic estrogen mestranol reduced mortality (2 of 11 versus 12 of 12 animals; P < 0.001 by Fisher's exact test), whereas 17-,-estradiol prolonged survival time. In experiment 3, 9-monthold rabbits were used, because older animals have been reported to be more susceptible to TSST-1 than 6-month-old rabbits (4) .
The relationship between survival and serum testosterone levels at the time of infection was exa,mined with three groups of rabbits ( Table 2 ). The groups included seven normal males (group A), seven castrated males which had testosterone implants (group B), and seven intact males which had mestranol implants (group C). Each rabbit is presented individually to better compare differences in the groups. The intact males (group A) had serum testosterone levels ranging from 1.2 to 5.9 ng/ml ( Table 2 ). This compares with published values of 1 to 4 ng/ml in 7-month-old rabbits (2) . Each of the intact rabbits in group A, except number 311, which had the lowest testosterone level in the group, died within 24 h of infection. As expected, group C rabbits which were treated with mestranol had lowered testosterone levels. Interestingly, rabbit 343 had a serum testosterone INFECT. IMMUN. level comparable to that of intact males not receiving mestranol and was the only rabbit in the group which did not survive. Each of the other rabbits in group C had serum testosterone levels below those consistently associated with mortality (see groups A and B, Table 2 ). A comparison of the testosterone levels observed in group B rabbits indicates the hormone pellets permitted consistent steroid levels to be established. The serum testosterone levels in untreated, castrated males were 81 ± 5.8 pg/ml (mean ± standard error), and 25-mg testosterone pellets restored the serum testosterone levels of the rabbits in group B to the lower range of normal.
The apparent association of serum testosterone with mortality in male rabbits prompted attempts to enhance the susceptibility of 6-month-old female rabbits by using testosterone or dihydrotestosterone implants to elevate serum androgen levels. Intact females had 123.9 ± 17.5 pg of testosterone per ml of serum, and testosterone implants elevated this level to between 1 and 3 ng/ml. However, neither androgen caused a significant increase (data not shown) in the mortality of either intact or gonadectomized female rabbits infected with S. aureus 555 (P > 0.1 by Fisher's exact test).
P4 at two levels was given to 6-and 9-month-old female rabbits to determine whether P4 itself, or perhaps metabolites of P4, could affect the mortality of female rabbits. Rabbits of both ages were used, because 9-month-old females are somewhat more susceptible to S. aureus infections than are younger animals. Assays for serum P4 were conducted on blood samples taken from each rabbit just before infection. The control animals had 442 ± 68 pg of P4 per ml at the time of infection. Pellets (25 mg) of P4 increased the level to 874 ± 78.5 pg/ml. The 100-mg pellets given to neutered females produced serum levels of 897 ± 69 pg/ml. P4 had no effect on the infections in female rabbits of either age when given in 25-or 100-mg pellets. If P4 were protective, this should have been evident when older females were used. If P4 enhanced mortality, this should have been observed when 6-month-old ovarihysterectomized rabbits were used (data not shown).
The close association of mortality with serum testosterone levels in male rabbits (9 of 9 rabbits with testosterone >1.7 ng/ml, 3 of 6 rabbits with testosterone of 1.6 to 1.7 ng/ml, and 0 of 6 rabbits with testosterone <1.6 ng/ml) indicates that the level of circulating androgen may be an important factor in determining host susceptibility to the toxin(s) of the TSS 
